Rothenberg Marc E, Hogan Simon P
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, USA.
Annu Rev Immunol. 2006;24:147-74. doi: 10.1146/annurev.immunol.24.021605.090720.
Eosinophils have been considered end-stage cells involved in host protection against parasites. However, numerous lines of evidence have now changed this perspective by showing that eosinophils are pleiotropic multifunctional leukocytes involved in initiation and propagation of diverse inflammatory responses, as well as modulators of innate and adaptive immunity. In this review, we summarize the biology of eosinophils, focusing on the growing properties of eosinophil-derived products, including the constituents of their granules as well as the mechanisms by which they release their pleiotropic mediators. We examine new views on the role of eosinophils in homeostatic function, including developmental biology and innate and adaptive immunity (as well as interaction with mast cells and T cells). The molecular steps involved in eosinophil development and trafficking are described, with special attention to the important role of the transcription factor GATA-1, the eosinophil-selective cytokine IL-5, and the eotaxin subfamily of chemokines. We also review the role of eosinophils in disease processes, including infections, asthma, and gastrointestinal disorders, and new data concerning genetically engineered eosinophil-deficient mice. Finally, strategies for targeted therapeutic intervention in eosinophil-mediated mucosal diseases are conceptualized.
嗜酸性粒细胞一直被认为是参与宿主抵御寄生虫的终末阶段细胞。然而,现在大量证据改变了这一观点,表明嗜酸性粒细胞是多效性的多功能白细胞,参与多种炎症反应的启动和传播,以及先天性和适应性免疫的调节。在这篇综述中,我们总结了嗜酸性粒细胞的生物学特性,重点关注嗜酸性粒细胞衍生产物不断增加的特性,包括其颗粒成分以及它们释放多效性介质的机制。我们研究了嗜酸性粒细胞在稳态功能中的作用的新观点,包括发育生物学、先天性和适应性免疫(以及与肥大细胞和T细胞的相互作用)。描述了嗜酸性粒细胞发育和迁移过程中涉及的分子步骤,特别关注转录因子GATA-1、嗜酸性粒细胞选择性细胞因子IL-5和趋化因子嗜酸性粒细胞趋化因子亚家族的重要作用。我们还综述了嗜酸性粒细胞在疾病过程中的作用,包括感染、哮喘和胃肠道疾病,以及有关基因工程嗜酸性粒细胞缺陷小鼠的新数据。最后,构思了针对嗜酸性粒细胞介导的黏膜疾病的靶向治疗干预策略。